REBECCA JOHNSON: Open Payments
NPI 1326107764 · LEHI, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$656 in 27 payments from 10 companies in 2025. Trend: 2023 $314 · 2024 $260 · 2025 $656
Food & beverage: $457Education: $199
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 11 | $363 |
| Sumitomo Pharma America, Inc. | 4 | $67 |
| Valencia Technologies Corporation | 1 | $50 |
| Organon LLC | 3 | $41 |
| Exeltis, USA Inc. | 2 | $36 |
| Biogen, Inc. | 2 | $31 |
| Biocomposites Inc | 1 | $22 |
| ABBVIE INC. | 1 | $18 |
| SHIELD THERAPEUTICS INC | 1 | $16 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $14 |
Products named: Veozah, MYFEMBREE, eCoin Device Kit, SLYND, ZURZUVAE, NEXPLANON, Stimulan, LILETTA.
Industry payments across UT — which companies pay providers there.
